Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 546 of 1,261
  1. US 10071358

    Antibiotic preparation method and platform system based on same

    PROTEIN DESIGN LAB, LTD. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  2. US 10072026

    Crystalline form of 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile

    Theravance Biopharma R&D IP, LLC · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  3. US 10071943

    Copper catalyzed [18F]fluorination of iodonium salts

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  4. US 10071150

    Immunity enhancing therapeutic vaccine for HPV and related diseases

    MYGT Biopharmaceutical LLC · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  5. US 10071123

    Treatment of pulmonary arterial hypertension with mesenchymal stem cells

    United Therapeutics Corporation · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  6. US 10071095

    1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders

    Addex Pharma, S.A. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  7. US 10071083

    Use of gaboxadol in the treatment of tinnitus

    OVID THERAPEUTICS INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  8. US 10071110

    Phosphonate compounds

    The Regents of the University of California · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  9. US 10071101

    Use of cinnabarinic acid as a modulator of immune response in autoimmune disorders

    The Regents of the University of California · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  10. US 10070631

    Rodents having a humanized TMPRSS gene

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  11. US 10071142

    Enzymes and methods for cleaving N-glycans from glycoproteins

    The Regents of the University of California · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  12. US 10071081

    Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

    PTC THERAPEUTICS, INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  13. US 10072062

    Methods and compositions for modification of a HLA locus

    The Board of Regents of the University of Texas System · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  14. US 10071168

    Polyoxazoline antibody drug conjugates

    Serina Therapeutics, Inc. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  15. US 10071945

    Nuclear receptor modulators and their use for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  16. US 10071976

    Small molecule fatty acid synthase inhibitors

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  17. US 10072070

    Potent anti-influenza A neuraminidase subtype N1 antibody

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  18. US 10072084

    Dual specific immunotoxin for brain tumor therapy

    The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  19. US 10064846

    Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  20. US 10064844

    Pharmaceutical compositions comprising an aromatse inhibitors

    MEREO BIOPHARMA 2 LIMITED · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  21. US 10064958

    Nipah virus envelope pseudotyped lentiviruses and methods of their use

    The Regents of the University of California · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  22. US 10064964

    Compounds and methods for the detection of TRPV-6 cancers and drug delivery

    Soricimed Biopharma Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  23. US 10065946

    Benzazole compounds and methods for making and using the compounds

    Rigel Pharmaceuticals, Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  24. US 10066017

    Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.